FDA
approval
· 2024-07-11
FDA Approved: XYZAL ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
Summary
The FDA approved a supplemental application for XYZAL ALLERGY 24HR (levocetirizine dihydrochloride) filed by Chattem, Inc., related to a supplement to the exist…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE)